Minimum effective volume of ultrasound-guided brachial plexus block with 0.375% ropivacaine for arteriovenous fistulas in patients with renal failure

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044031

Enrollment

Unknown

Registered

2021-03-06

Start date

2021-03-06

Completion date

Unknown

Last updated

2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal failure

Interventions

1:ultrasound-guided brachial plexus block with 0.375% ropivacaine

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: All adult patients(aged 18 years to 65 years)who are having fistulae created are eligible to participate and obtaining written informed consent.

Exclusion criteria

Exclusion criteria: 1.BMI 35 kg/m2; 2.Patients with contrain dications to regional anaesthesia or peripheral neuropathy; 3.Liver failure, heart failure, sepsis; 4.Patients unable to communicate in Mandarin; 5.Participation in other studies.

Design outcomes

Primary

Measure	Time frame
the minimum effective volume for successful block in 95% of the patients;the minimum effective volume for successful block in 50% of the patients;	—

Countries

China

Contacts

Public ContactLiu Weifeng

NANFANG HOSPITAL SOUTHERN MEDICAL UNIVERSITY

sglwfeng01@21cn.com+86 13826003364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026